Journals / Ulusal Travma ve Acil Cerrahi Dergisi / 2016 / Cilt: 22 - Sayı: 2

Sepsis nedenli akut böbrek hasarında agomelatinin etkilerinin değerlendirilmesi

Beneficial effects of agomelatine in experimental model of sepsis-related acute kidney injury

Pages
121–126
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is believed that antioxidant and pro-inflammatory effects of agomelatine are responsible for the improvement in kidneys.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND: Sepsis-related acute kidney injury (AKI) is a serious complication of sepsis.
📊
Key Findings & Data:Rats were separated into 4 groups of 8 each: the control group, the sham-operated group, the CLP+saline group, and the CLP+agomelatine group.
💡
Conclusion & Impact:It is believed that antioxidant and pro-inflammatory effects of agomelatine are responsible for the improvement in kidneys.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

BACKGROUND: Sepsis-related acute kidney injury (AKI) is a serious complication of sepsis. Problems persist regarding early diagnosis and treatment of AKI. The aim of the present study was to evaluate the efficacy of agomelatine, which is primarily known for its positive effects on depressive and anxiety disorders in sepsis-related AKI.METHODS: Sepsis model was created with cecal ligation puncture (CLP). Rats were separated into 4 groups of 8 each: the control group, the sham-operated group, the CLP+saline group, and the CLP+agomelatine group. Agomelatine was administered intraperitoneally in doses of 20 mg/kg.RESULTS: In the agomelatine group, reductions were observed in levels of tumor necrosis factor ? (TNF-?), malondialdehyde (MDA), blood urea nitrogen (BUN), and creatinine, as well as in histological kidney scores, compared to the non-treated group. In addition, it was demonstrated that agomelatine treatment had positive effect on sepsis-induced morphological damage to renal and tubular tissues.CONCLUSION: Agomelatine showed strong efficacy in sepsis-related AKI, demonstrated with histological and biochemical results in an experimental model. It is believed that antioxidant and pro-inflammatory effects of agomelatine are responsible for the improvement in kidneys.

Özet

AMAÇ: Sepsis nedenli akut böbrek hasarı sepsisin önemli komplikasyonlarından biridir. Sepsisin erken dönemlerinde gelişir ve mortaliteyi artırır. Hem erken tanı sürecinde hem de tedavi aşamasında hala problemler vardır. Bu çalışmanın amacı, genellikle anksiyete ve depresyonda kullanılan agomelatinin sepsis nedenli akut böbrek hasarındaki olası etkilerinin değerlendirilmesidir. GEREÇ VE YÖNTEM: Sepsis modeli çekal ligasyon ve delme (CLP) tekniği ile oluşturuldu. Sıçanlar her biri sekizerli dört gruba ayrıldı. İlk grup normal, ikinci grup sham grubu olarak belirlendi. Üçüncü grup sepsis modeli oluşturulup sadece salin verilen grup, dördüncü grup ise sepsis modelini takiben agomelatin uygulanan grup olarak belirlendi. Yirmi dört saatin sonunda böbrek doku örnekleri ve kanlar alınarak histopatolojik ve biyokimyasal yöntemlerle analizleri yapıldı. BULGULAR: Çalışmada agomelatine uygulanan grupta sadece salin uygulanan gruba göre TNF-?, MDA, BUN, kreatin ve histolojik böbrek skorlaması daha düşük olarak bulundu. Aynı zamanda, histopatolojik değerlendirmede agomelatin tedavisinin böbrek dokularında sepsisin oluşturduğu hasarlanmayı düzelttiği görüldü. TARTIŞMA: Bu çalışmada, agomelatinin sepsis nedenli akut böbrek hasarında faydalı olduğu savunulmaktadır. Bu hem biyokimyasal hem de histolojik değerlendirmeler ile gösterilmiştir. Agomelatinin anti-oksidan ve proenflamatuvar etkilerinin böbreklerdeki bu düzelmeden sorumlu olduğu düşünülmektedir.

🔖

Cite This Article

BAŞOL, N., ERBAS, O., ÇAVUŞOĞLU, T., MERAL, A., ATEŞ, U. (2016). Sepsis nedenli akut böbrek hasarında agomelatinin etkilerinin değerlendirilmesi. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 22 - Sayı: 2, 121–126. https://ajindex.com/articles/324001

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Wang HE, Shapiro NI, Safford MM, Griffin R, Judd S, Rodgers JB, et al. High-sensitivity C-reactive protein and risk of sepsis. PLoS One 2013;8:e69232. Hecker A, Uhle F, Schwandner T, Padberg W, Weigand MA. Diagnos- tics, therapy and outcome prediction in abdominal sepsis: current stan- dards and future perspectives. Langenbecks Arch Surg 2014;399:11-22.
  2. Bozza FA, D'Avila JC, Ritter C, Sonneville R, Sharshar T, Dal-Pizzol F. Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock 2013;39 Suppl 1:10-6.
  3. Seija M, Baccino C, Nin N, Sánchez-Rodríguez C, Granados R, Ferruelo A, et al. Role of peroxynitrite in sepsis-induced acute kidney injury in an experimental model of sepsis in rats. Shock 2012;38:403-10.
  4. Mayeux PR, MacMillan-Crow LA. Pharmacological targets in the re- nal peritubular microenvironment: implications for therapy for sepsis- induced acute kidney injury. Pharmacol Ther 2012;134:139-55.
  5. Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care 2013;17:R278. Adembri C, Selmi V, Vitali L, Nosi D, Tani A, Thyrion GD, et al. Expres- sion and characterization of anionic components in the tubulointerstitial compartment of rat kidney during polymicrobial sepsis. Acta Histochem 2014;116:94-105. Jakovljevic M. Agomelatine as chronopsychopharmaceutics restoring cir- cadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression? Psychiatr Danub 2011;23:2-9.
  6. Boyce P, Barriball E. Circadian rhythms and depression. Aust Fam Physi- cian 2010;39:307-10.
  7. Fornaro M, Prestia D, Colicchio S, Perugi G. A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr Neuropharmacol 2010;8:287-304.
  8. Eser D, Baghai TC, Möller HJ. Agomelatine: The evidence for its place in the treatment of depression. Core Evid 2010;4:171-9. Wheeler DS. Oxidative Stress in Critically Ill Children with Sepsis. Open Inflamm J 2011;4:74-81.
  9. Lowes DA, Webster NR, Murphy MP, Galley HF. Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dys- function in a rat model of acute sepsis. Br J Anaesth 2013;110:472-80.
  10. Srinivasan V, Pandi-Perumal SR, Spence DW, Kato H,